Marielle König-Schuster

Title: Marielle Konig-Schuster: Innovator in Antiviral Research

Introduction

Marielle Konig-Schuster is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of antiviral research, particularly in the development of innovative medicaments. Her work focuses on addressing infections caused by influenza viruses.

Latest Patents

Marielle holds a patent for a synergistic antiviral composition that combines iota- and/or kappa-carrageenan with a neuraminidase inhibitor. This invention is aimed at providing a prophylactic or therapeutic treatment for symptoms, conditions, or diseases associated with influenza virus infections. The patent highlights her commitment to advancing medical science and improving public health.

Career Highlights

Throughout her career, Marielle has been associated with Marinomed Biotechnologie GmbH, a company known for its cutting-edge research in biotechnology. Her role at the company has allowed her to explore innovative solutions to combat viral infections.

Collaborations

Marielle has collaborated with notable colleagues, including Andreas Grassauer and Eva Prieschl-Grassauer. These partnerships have fostered a collaborative environment that enhances the research and development of antiviral therapies.

Conclusion

Marielle Konig-Schuster is a trailblazer in antiviral research, with a focus on innovative treatments for influenza virus infections. Her contributions through patents and collaborations underscore her dedication to improving health outcomes.